Literature DB >> 107819

Serological differences between acute and chronic schistosomiasis mansoni detected by enzyme-linked immunosorbent assay (ELISA).

M N Lunde, E A Ottesen, A W Cheever.   

Abstract

Sera from patients with acute and chronic schistosomiasis mansoni, and from laboratory-infected monkeys, were examined by an enzyme-linked immunosorbent assay technique using antigens prepared from eggs, cercariae, and adult worms. Sera from patients with acute schistosomiasis and from monkeys 2 months post-infection reacted more positively to cercarial antigen than to adult worm antigen whereas sera from both patients with chronic schistosomiasis and monkeys infected for longer than 4 months reacted more positively to adult worm antigen. These differential responses to antigen serologically differentiated between acute and chronic schistosome infections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 107819     DOI: 10.4269/ajtmh.1979.28.87

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

1.  Comparative analysis of the diagnostic performance of adult, cercarial and egg antigens assessed by ELISA, in the diagnosis of chronic human Schistosoma mansoni infection.

Authors:  Rania Mohammad Sarhan; Heba AbdelKader Aminou; Ghada Abdel Rahman Saad; Ossama Ashraf Ahmed
Journal:  Parasitol Res       Date:  2014-07-16       Impact factor: 2.289

Review 2.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

3.  Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.

Authors:  Pauline N M Mwinzi; Lisa Ganley-Leal; Carla L Black; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

4.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

5.  Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes.

Authors:  Claudia Carvalho-Queiroz; Rosemary Cook; Ching C Wang; Rodrigo Correa-Oliveira; Nicola A Bailey; Nejat K Egilmez; Edith Mathiowitz; Philip T LoVerde
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

6.  Defective immunoglobulin M responses to vaccination or infection with Schistosoma mansoni in xid mice.

Authors:  R Correa-Oliveira; A Sher
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.